Clinical development of molecular residual disease (MRD) and multi-cancer early detection (MCED) using liquid biopsy multiomics with artificial intelligence (AI)
利用液体活检多组学和人工智能 (AI) 进行分子残留病灶 (MRD) 和多癌早期检测 (MCED) 的临床开发
期刊:International Journal of Clinical Oncology
影响因子:2.8
doi:10.1007/s10147-026-03001-6
Shibuki, Taro; Yamashita, Riu; Hashimoto, Tadayoshi; Fujisawa, Takao; Imai, Mitsuho; Yuda, Junichiro; Kuwata, Takeshi; Misumi, Toshihiro; Nakamura, Yoshiaki; Bando, Hideaki; Kojima, Kaname; Tokioka, Sayuri; Chiba, Ippei; Nakaya, Naoki; Hozawa, Atsushi; Koshiba, Seizo; Fuse, Nobuo; Saito, Sakae; Shimizu, Ritsuko; Park, Woong-Yang; Kinoshita, Kengo; Yoshino, Takayuki